New LED Microscope Completes Line of Clinical and Research Tools
|
By LabMedica International staff writers Posted on 26 Jul 2015 |
A popular microscope used for both clinical and research applications is now available with LED illumination.
The Leica (Wetzlar, Germany) DM2500 and DM2500 LED microscopes represent a class of tools for demanding tasks in life science routine and research applications. With their powerful transmitted light illumination, high-quality optical performance, and state-of-the-art accessories, the Leica DM2500 and DM2500 LED are especially well-suited for challenging life science research tasks that require differential interference contrast or high-performance fluorescence.
The difference between the two microscopes is their illumination: The Leica DM2500 LED is equipped with LED illumination for transmitted light, whereas the Leica DM2500 works with halogen. Both types of illumination render a realistic impression of the colors of the sample, so that users in clinical applications, such as the frequently used HE specimen staining, are able to assess the colors of their samples accurately. With the launch of the Leica DM2500 LED, Leica Microsystems has completed its Leica DM1000 to 3000 series of microscopes. All the models in this series are now available with LED illumination. The microscopes are certified for in vitro diagnostics (IVD) use.
The ultra-bright LED illumination of the newly released Leica DM2500 LED offers a constant color temperature at all light intensities, enabling particularly fine differentiation of colors in stained specimens. Users benefit from the brightness and color accuracy of the LED illumination in all other transmitted light contrasting techniques, such as brightfield, polarized light, and darkfield. LEDs offer the general advantages of no sample heating, low energy consumption, and long life time.
"The specially-developed LED illumination makes the Leica DM2500 LED an ideal microscope for challenging experiments requiring different contrasting techniques and for users who prefer a manual instrument," said Dr. Jasna Gilbert, product manager at Leica Microsystems. "The Leica DM2500 LED has now completed our DM1000 to 3000 series. All the models are available with either LED or halogen illumination. Besides the new illumination, the Leica DM2500 LED offers all the other benefits of the microscope series such as the unique ergonomics design for user comfort and convenience."
Related Links:
Leica
The Leica (Wetzlar, Germany) DM2500 and DM2500 LED microscopes represent a class of tools for demanding tasks in life science routine and research applications. With their powerful transmitted light illumination, high-quality optical performance, and state-of-the-art accessories, the Leica DM2500 and DM2500 LED are especially well-suited for challenging life science research tasks that require differential interference contrast or high-performance fluorescence.
The difference between the two microscopes is their illumination: The Leica DM2500 LED is equipped with LED illumination for transmitted light, whereas the Leica DM2500 works with halogen. Both types of illumination render a realistic impression of the colors of the sample, so that users in clinical applications, such as the frequently used HE specimen staining, are able to assess the colors of their samples accurately. With the launch of the Leica DM2500 LED, Leica Microsystems has completed its Leica DM1000 to 3000 series of microscopes. All the models in this series are now available with LED illumination. The microscopes are certified for in vitro diagnostics (IVD) use.
The ultra-bright LED illumination of the newly released Leica DM2500 LED offers a constant color temperature at all light intensities, enabling particularly fine differentiation of colors in stained specimens. Users benefit from the brightness and color accuracy of the LED illumination in all other transmitted light contrasting techniques, such as brightfield, polarized light, and darkfield. LEDs offer the general advantages of no sample heating, low energy consumption, and long life time.
"The specially-developed LED illumination makes the Leica DM2500 LED an ideal microscope for challenging experiments requiring different contrasting techniques and for users who prefer a manual instrument," said Dr. Jasna Gilbert, product manager at Leica Microsystems. "The Leica DM2500 LED has now completed our DM1000 to 3000 series. All the models are available with either LED or halogen illumination. Besides the new illumination, the Leica DM2500 LED offers all the other benefits of the microscope series such as the unique ergonomics design for user comfort and convenience."
Related Links:
Leica
Read the full article by registering today, it's FREE!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
- Free digital version edition of LabMedica International sent by email on regular basis
- Free print version of LabMedica International magazine (available only outside USA and Canada).
- Free and unlimited access to back issues of LabMedica International in digital format
- Free LabMedica International Newsletter sent every week containing the latest news
- Free breaking news sent via email
- Free access to Events Calendar
- Free access to LinkXpress new product services
- REGISTRATION IS FREE AND EASY!
Sign in: Registered website members
Sign in: Registered magazine subscribers
Latest BioResearch News
- Study Identifies Distinct Immune Signatures to Early Depression and Psychosis
- Genetic Mutation Behind Aggressive Adult Leukemia Offers Treatment Clues
- Disease Gene Discovery Advances Diagnosis of Rare Movement Disorders
- Genetic Discovery Could Improve Diagnosis of Drug-Resistant Epilepsy
- Genetic Discovery May Improve Diagnosis of Rare Dementia Subtype
- Mass Spectrometry Technique Detects Protein and Sugar Changes in Neurodegeneration
- Barcoded DNA Sheds Light on Hidden Complexities in Breast Cancer Detection
- CRISPR-Based Platform Pinpoints Drivers of Acute Myeloid Leukemia in Patient Cells
- Protective Brain Protein Emerges as Biomarker Target in Alzheimer’s Disease
- Genome Analysis Predicts Likelihood of Neurodisability in Oxygen-Deprived Newborns
- Gene Panel Predicts Disease Progession for Patients with B-cell Lymphoma
- New Method Simplifies Preparation of Tumor Genomic DNA Libraries
- New Tool Developed for Diagnosis of Chronic HBV Infection
- Panel of Genetic Loci Accurately Predicts Risk of Developing Gout
- Disrupted TGFB Signaling Linked to Increased Cancer-Related Bacteria
- Gene Fusion Protein Proposed as Prostate Cancer Biomarker
Channels
Clinical Chemistry
view channel
Blood-Based Screening Test Targets Early Detection of Colorectal Cancer
Colorectal cancer (CRC) is a leading cause of cancer-related death worldwide, with more than 60% of cases still diagnosed at a late stage. Uptake of existing screening tools remains suboptimal,... Read more
Automated NfL Assay Supports Monitoring of Neurological Disorders
Neuroaxonal injury occurs across a wide range of neurological disorders and remains difficult to monitor noninvasively over time. Blood-based measurement of neurofilament light chain (NfL) provides a biologically... Read moreMolecular Diagnostics
view channel
New Respiratory Panel Expands Pathogen Detection to 25 Targets
Respiratory infections often present with overlapping symptoms, complicating differential diagnosis in acute and community settings. The stakes are higher for older adults, young children, and people with... Read more
Simple Nasal Swab May Reveal Early Signs of Alzheimer’s Disease
Alzheimer’s disease affects millions worldwide but remains difficult to detect at its earliest, pre-symptomatic stage. Clinicians need tools that can identify biological changes before cognitive symptoms... Read moreHematology
view channel
Rapid Cartridge-Based Test Aims to Expand Access to Hemoglobin Disorder Diagnosis
Sickle cell disease and beta thalassemia are hemoglobin disorders that often require referral to specialized laboratories for definitive diagnosis, delaying results for patients and clinicians.... Read more
New Guidelines Aim to Improve AL Amyloidosis Diagnosis
Light chain (AL) amyloidosis is a rare, life-threatening bone marrow disorder in which abnormal amyloid proteins accumulate in organs. Approximately 3,260 people in the United States are diagnosed... Read moreImmunology
view channel
Study Identifies Inflammatory Pathway Driving Immunotherapy Resistance in Bladder Cancer
Bladder cancer remains a prevalent malignancy with variable responses to immune checkpoint inhibitors. Clinicians often observe elevated C-reactive protein and interleukin-6 in affected patients, yet the... Read more
Microfluidic Chip Detects Cancer Recurrence from Immune Response Signals
Early identification of treatment response and relapse remains a major challenge in solid tumors, where minimal residual disease is difficult to detect with routine imaging and blood tests.... Read moreMicrobiology
view channel
Breath Analysis Approach Offers Rapid Detection of Bacterial Infection
Accurate and rapid identification of bacterial infections remains challenging in acute care, where delays can hinder timely, targeted therapy. Infectious diseases are a major cause of mortality worldwide,... Read more
Study Highlights Accuracy Gaps in Consumer Gut Microbiome Kits
Direct-to-consumer gut microbiome kits promise personalized insights by profiling fecal bacteria and generating health readouts, but their analytical accuracy remains uncertain. A new study shows that... Read more
WHO Recommends Near POC Tests, Tongue Swabs and Sputum Pooling for TB Diagnosis
Tuberculosis (TB) remains one of the world’s leading infectious disease killers, yet millions of cases go undiagnosed or are detected too late. Barriers such as reliance on sputum samples, limited laboratory... Read morePathology
view channel
Biopsy-Based Gene Test Predicts Recurrence Risk in Lung Adenocarcinoma
Lung cancer is the leading cause of cancer death, killing more people in the United States than breast, prostate, and colon cancers combined. In lung adenocarcinoma (LUAD), tumors that invade nearby blood... Read more
AI-Powered Tool to Transform Dermatopathology Workflow
Skin cancer accounts for the largest number of cancer diagnoses in the United States, placing sustained pressure on pathology services. Diagnostic interpretation can be variable for challenging melanocytic... Read moreTechnology
view channel
Online Tool Supports Family Screening for Inherited Cancer Risk
Genetic test results in oncology often have implications for relatives who may share inherited cancer risk. Many health systems lack structured processes to help patients alert family members, limiting... Read more
Portable Breath Sensor Detects Pneumonia Biomarkers in Minutes
Pneumonia is commonly confirmed with chest X-rays or laboratory assays that can take hours, delaying clinical decisions in acute and outpatient settings. Breath-based diagnostics promise faster answers... Read moreIndustry
view channel
Integrated DNA Technologies Expands into Clinical Diagnostics
Integrated DNA Technologies (IDT; Coralville, Iowa, USA) has announced the launch of Archer FUSIONPlex-HT Dx and VARIANTPlex-HT Dx. This launch marks the company’s first in vitro diagnostic (IVD) offerings... Read more









